Boston Scientific logo

BSXBoston Scientific

Pharma & Healthcare · US · Boston Scientific Corporation

6 of 6 ratios computed · receipts verified server-side

Idiot Index
17
out of 100 · 6/6 ratios · FY 2023

The full receipt

Latest published value for each ratio, with the sector median for context and year-over-year change where the prior year is available.

  • Markup

    How much revenue per dollar of cost.

    3.2034× revenue / costverified
    $1 of cost becomes $3.20 of revenue
    Sector median: 3.1882Median range for extraction in sector
    FY 2023v1.0.0
  • Operational Markup

    Revenue per dollar of cost + operating expenses. The multiplier after legitimate operations.

    1.1122× revenue / (cost + opex)verified
    $1 of cost+opex becomes $1.11 of revenue
    Sector median: 1.2871Bottom 20% for extraction in sector
    FY 2023v1.0.0
  • Labor Share

    How much of every revenue dollar reaches workers.

    0.2842of revenue → workersapprox.verified
    28¢ of every $1 of revenue reaches workers
    Sector median: 0.1761Median range for extraction in sector
    FY 2023v1.0.0
  • Executive Extraction

    How many times a CEO out-earns the median employee.

    345.8× CEO / median workerverified
    CEO earns 346× the median worker
    Sector median: 263.0Top 22% for extraction in sector
    FY 2023v1.0.0
  • Shareholder Extraction

    Dollars sent to shareholders for every dollar invested in R&D.

    0.0457× buybacks+dividends / R&Dverified
    $0.05 to shareholders per $1 in R&D — net reinvesting
    Sector median: 0.7492Bottom 15% for extraction in sector
    FY 2023v1.0.0
  • Capital Extraction

    How much of net profit goes to shareholders rather than back into the business.

    0.0528× buybacks+dividends / net incomeverified
    5% of net profit returned to shareholders, 95% reinvested
    Sector median: 0.5294Bottom 13% for extraction in sector
    FY 2023v1.0.0

Company response

No verified response yet. If you represent Boston Scientific, you can add context, agree, or dispute.

Source data

Every raw line item this company disclosed in its XBRL filings. Click any filing to view the original on SEC.gov.

FY 2023· 9 facts
ConceptValueUnitPeriodFilingReceipt
CEO Total Compensation
CEOTotalCompensation
18,723,735USDFY0000885725-24-000033verified
Cost of Goods Sold
CostOfGoodsAndServicesSold
3,711,000,000USDFY0000885725-24-000017verified
Dividends Paid
PaymentsOfDividends
55,000,000USDFY0000885725-24-000017verified
Median Employee Compensation
MedianEmployeeCompensation
54,147USDFY0000885725-24-000033verified
Net Income
ProfitLoss
1,041,000,000USDFY0000885725-24-000017verified
Operating Expenses
OperatingExpenses
6,978,000,000USDFY0000885725-24-000017verified
R&D Expense
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1,204,000,000USDFY0000885725-24-000017verified
Revenue
RevenueFromContractWithCustomerExcludingAssessedTax
11,888,000,000USDFY0000885725-24-000017verified
Total Employee Count
TotalEmployees
48,000employeesFY0000885725-24-000033verified